Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
Mie Jin Lim, Seong Ryul Kwon, Kowoon Joo, Min Jung Son, Shin-Goo Park, Won Park
Korean J Intern Med. 2014;29(6):807-813. Published online 2014 Oct 31 DOI: https://doi.org/10.3904/kjim.2014.29.6.807
Citations to this article as recorded by 
Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation
Ignacio Gómez-García, Maria L. Ladehesa-Pineda, Juan M. Diaz-Tocados, Clementina López-Medina, Maria C. Abalos-Aguilera, Desiree Ruiz-Vilches, Guillermo Paz-Lopez, Andres Gonzalez-Jimenez, Juan A. G. Ranea, Alejandro Escudero-Contreras, Isabel Moreno-Indi
Frontiers in Endocrinology.2024;[Epub] CrossRef
Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor Therapy
Anna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, Krystyna Olczyk, Katarzyna Komosińska-Vassev
Pharmaceuticals.2024; 17(6): 666. CrossRef
The Role of Sclerostin in Rheumatic Diseases: A Review
Łukasz Jaśkiewicz, Grzegorz Chmielewski, Jakub Kuna, Tomasz Stompór, Magdalena Krajewska-Włodarczyk
Journal of Clinical Medicine.2023; 12(19): 6248. CrossRef
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Boglárka Soós, Ágnes Szentpétery, Hennie G. Raterman, Willem F. Lems, Harjit P. Bhattoa, Zoltán Szekanecz
Nature Reviews Rheumatology.2022; 18(5): 249. CrossRef
Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study
Jung Sun Lee, Doo-Ho Lim, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
Rheumatology International.2020; 40(3): 481. CrossRef
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis
Katalin Gulyás, Ágnes Horváth, Edit Végh, Anita Pusztai, Ágnes Szentpétery, Zsófia Pethö, Andrea Váncsa, Nóra Bodnár, Péter Csomor, Attila Hamar, Levente Bodoki, Harjit Pal Bhattoa, Balázs Juhász, Zoltán Nagy, Katalin Hodosi, Tamás Karosi, Oliver FitzGera
Clinical Rheumatology.2020; 39(1): 167. CrossRef
Hydrocortisone decreases lethality and inflammatory cytokine and nitric oxide production in rats challenged with B. anthracis cell wall peptidoglycan
Yan Li, Xizhong Cui, Joseph Shiloach, Jeffrey Wang, Dante A. Suffredini, Wanying Xu, Wancang Liu, Yvonne Fitz, Junfeng Sun, Peter Q. Eichacker
Intensive Care Medicine Experimental.2020;[Epub] CrossRef
Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
Inês P. Perpétuo, Joana Caetano-Lopes, Ana Maria Rodrigues, Raquel Campanilho-Marques, Cristina Ponte, Helena Canhão, Mari Ainola, João E. Fonseca
BioMed Research International.2017; 2017: 1. CrossRef
Effects of targeted therapies on the bone in arthritides
Ágnes Szentpétery, Ágnes Horváth, Katalin Gulyás, Zsófia Pethö, Harjit Pal Bhattoa, Sándor Szántó, Gabriella Szücs, Oliver FitzGerald, Georg Schett, Zoltán Szekanecz
Autoimmunity Reviews.2017; 16(3): 313. CrossRef
Sclerostin as an innovative insight towards understanding Rheumatoid Arthritis
Samah El-Bakry, Nayera Saber, Hoyawda Zidan, Dalia Samaha
The Egyptian Rheumatologist.2016; 38(2): 71. CrossRef
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis
Giovanni Orsolini, Giovanni Adami, Silvano Adami, Ombretta Viapiana, Luca Idolazzi, Davide Gatti, Maurizio Rossini
Calcified Tissue International.2016; 98(6): 580. CrossRef
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis
Giovanni Adami, Giovanni Orsolini, Silvano Adami, Ombretta Viapiana, Luca Idolazzi, Davide Gatti, Maurizio Rossini
Calcified Tissue International.2016; 99(4): 360. CrossRef
Bone and TNF in rheumatoid arthritis: clinical implications
Maria Manara, Luigi Sinigaglia
RMD Open.2015; 1(Suppl 1): e000065. CrossRef